calcimedica inc glp-1 receptor agonists weight management diabetes treatments

calcimedica inc glp-1 receptor agonists weight management diabetes treatments Mapping the effectiveness and risks of Weight Reduction with GLP-1 Agonists

Name: calcimedica inc glp-1 receptor agonists weight management diabetes treatments Mapping the effectiveness and risks of Weight Reduction with GLP-1 Agonists
Brand: www.himachallive.in
SKU: 38956532125
Price: 20.31 USD
Availability: InStock
Rating: 4.0288 (10 reviews)

SKU: 38956532125

4.0

USD20.31 USD56.31

Pay in 4 interest-free payments of $5.08 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells

Alanine, aspartate, and glutamate metabolism ( Figure 8b ) was the most significantly impacted pathway, with a p-value of 8.73E-05 ([-log 10 (p) = 4.059]) and an impact score of 0.28606, as detailed in Table 4